Cannabis effective in killing skin cancer cells, study finds

A groundbreaking in vitro study published in the journal Cells, reveals the potential efficacy of a cannabis extract, PHEC-66 (which contains around 60% of CBD, as far as we could find), in inducing cell death in melanoma tumors, a type of skin cancer notoriously linked to sun exposure.

Conducted by researchers at Australia's Charles Darwin University (CDU) and the Royal Melbourne Institute of Technology (RMIT), this research marks a significant advance in our understanding of the therapeutic implications of cannabinoids in oncology.

As RMIT's Dr Ava Bachari explains, the mechanism underlying PHEC-66's action lies in its interaction with receptors present in melanoma cells. This interaction not only retards cell growth, but also exacerbates damage within malignant cells, ultimately leading to programmed cell death, or apoptosis.

Dr Nazim Nassar, co-author of the study and Professor of Pharmacy at CDU, notes the importance of understanding the interaction of cannabis extracts with cancer cells, emphasizing the possibility of refining treatment modalities to improve specificity and efficacy.

The appeal of cannabis extracts in cancer treatment does not depend solely on this study. Indeed, the research community has been investigating the therapeutic potential of cannabinoids for a variety of conditions, from anxiety to chronic pain. However, the study highlights a new avenue in cancer therapy, particularly in the treatment of melanoma. Dr. Nassar explains the significance of this research not only for melanoma, but also for laying the foundations for exploring the efficacy of cannabis extracts in other types of cancer.

But while the results of the study are promising, they are based on an experiment. in vitro. Looking ahead, the researchers are ready to take up the challenge of translating these results into clinical applications. For this, it will be necessary to develop an effective delivery system for PHEC-66, a crucial step that precedes preclinical trials.

The study's findings could offer a glimmer of hope in the fervent quest for new cancer therapies. The prospect of using cannabis extracts as a powerful weapon against melanoma amplifies the need for further exploration and investment in cannabinoid research.